Invention Grant
US08410125B2 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias 有权
用于治疗上皮增生的胸苷的磺化前体

  • Patent Title: Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
  • Patent Title (中): 用于治疗上皮增生的胸苷的磺化前体
  • Application No.: US12741419
    Application Date: 2008-11-05
  • Publication No.: US08410125B2
    Publication Date: 2013-04-02
  • Inventor: Giuseppe Trigiante
  • Applicant: Giuseppe Trigiante
  • Applicant Address: GB London
  • Assignee: Yagna Limited
  • Current Assignee: Yagna Limited
  • Current Assignee Address: GB London
  • Agency: MDIP LLC
  • International Application: PCT/GB2008/003727 WO 20081105
  • International Announcement: WO2009/060186 WO 20090514
  • Main IPC: A61K31/505
  • IPC: A61K31/505
Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias
Abstract:
This invention relates to pharmaceutical compositions comprising a sulfonated biological precursor of thymidine, such as a precursor of 4-thiothymidine (4-TT), and their use in the photodynamic treatment of skin hyperplasias, including cancer, psoriasis, actinic keratosis and keloids, by topical or systemic administration.
Information query
Patent Agency Ranking
0/0